Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Gastric Cancer

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 66 articles:
HTML format



Single Articles


    June 2020
  1. ARNOLD M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I, et al
    Global burden of oesophageal and gastric cancer by histology and subsite in 2018.
    Gut. 2020 Jun 30. pii: gutjnl-2020-321600. doi: 10.1136/gutjnl-2020-321600.
    PubMed     Abstract available


  2. BORNSCHEIN J, Rugge M
    Bright future for endoscopy: the new frontier of gastric cancer secondary prevention.
    Gut. 2020 Jun 12. pii: gutjnl-2020-321570. doi: 10.1136/gutjnl-2020-321570.
    PubMed    


  3. HATTA W, Tsuji Y, Yoshio T, Kakushima N, et al
    Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score.
    Gut. 2020 Jun 4. pii: gutjnl-2019-319926. doi: 10.1136/gutjnl-2019-319926.
    PubMed     Abstract available


    April 2020
  4. YOSHIDA N, Doyama H, Yano T, Horimatsu T, et al
    Early gastric cancer detection in high-risk patients: a multicentre randomised controlled trial on the effect of second-generation narrow band imaging.
    Gut. 2020 Apr 2. pii: gutjnl-2019-319631. doi: 10.1136/gutjnl-2019-319631.
    PubMed     Abstract available


    March 2020
  5. FORD AC, Yuan Y, Moayyedi P
    Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis.
    Gut. 2020 Mar 23. pii: gutjnl-2020-320839. doi: 10.1136/gutjnl-2020-320839.
    PubMed     Abstract available


  6. KOLB JM, Leong S, Westbrook LM, Patel SG, et al
    Aggressive case of early onset gastric cancer; identifying the knowledge gap.
    Gut. 2020 Mar 11. pii: gutjnl-2019-320453. doi: 10.1136/gutjnl-2019-320453.
    PubMed    


  7. YAMAJI Y, Hirata Y
    Treatment for Helicobacter pylori appears to reduce the incidence of gastric cancer: eradication effect or screening effect?
    Gut. 2020;69:605-606.
    PubMed    


    February 2020
  8. MAEDA M, Takeshima H, Iida N, Hattori N, et al
    Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3.
    Gut. 2020;69:243-251.
    PubMed     Abstract available


    January 2020
  9. ARNOLD M, Park JY, Camargo MC, Lunet N, et al
    Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035.
    Gut. 2020 Jan 30. pii: gutjnl-2019-320234. doi: 10.1136/gutjnl-2019-320234.
    PubMed     Abstract available


  10. DING L, Li Q, Chakrabarti J, Munoz A, et al
    MiR130b from Schlafen4(+) MDSCs stimulates epithelial proliferation and correlates with preneoplastic changes prior to gastric cancer.
    Gut. 2020 Jan 24. pii: gutjnl-2019-318817. doi: 10.1136/gutjnl-2019-318817.
    PubMed     Abstract available


  11. ERAWIJANTARI PP, Mizutani S, Shiroma H, Shiba S, et al
    Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles.
    Gut. 2020 Jan 16. pii: gutjnl-2019-319188. doi: 10.1136/gutjnl-2019-319188.
    PubMed     Abstract available


  12. GUIMARAES P, Keller A, Fehlmann T, Lammert F, et al
    Deep-learning based detection of gastric precancerous conditions.
    Gut. 2020;69:4-6.
    PubMed    


  13. WANG R, Song S, Harada K, Ghazanfari Amlashi F, et al
    Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
    Gut. 2020;69:18-31.
    PubMed     Abstract available


    December 2019
  14. GUO Y, Zhang Y, Gerhard M, Gao JJ, et al
    Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer.
    Gut. 2019 Dec 19. pii: gutjnl-2019-319696. doi: 10.1136/gutjnl-2019-319696.
    PubMed     Abstract available


  15. COSTA L, Corre S, Michel V, Le Luel K, et al
    USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis.
    Gut. 2019 Dec 10. pii: gutjnl-2019-318640. doi: 10.1136/gutjnl-2019-318640.
    PubMed     Abstract available


    October 2019
  16. JANSEN M, Banks M
    Early detection and risk stratification of gastric cancer are likely to be refined with biopsies targeted through high-resolution-enhanced imaging.
    Gut. 2019 Oct 14. pii: gutjnl-2019-319921. doi: 10.1136/gutjnl-2019-319921.
    PubMed    


  17. WANG Q, Chen C, Ding Q, Zhao Y, et al
    METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance.
    Gut. 2019 Oct 3. pii: gutjnl-2019-319639. doi: 10.1136/gutjnl-2019-319639.
    PubMed     Abstract available


    September 2019
  18. LIU K, Qin M, Huang J
    The prescreening tool for gastric cancer in China.
    Gut. 2019 Sep 3. pii: gutjnl-2019-319591. doi: 10.1136/gutjnl-2019-319591.
    PubMed    


  19. CHEUNG KS, Leung WK
    Response to letter to the editor by Moayyedi et al.
    Gut. 2019;68:1721-1722.
    PubMed    


  20. BANKS M, Graham D, Jansen M, Gotoda T, et al
    British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.
    Gut. 2019;68:1545-1575.
    PubMed     Abstract available


    August 2019
  21. YAN C, Zhu M, Ding Y, Yang M, et al
    Meta-analysis of genome-wide association studies and functional assays decipher susceptibility genes for gastric cancer in Chinese populations.
    Gut. 2019 Aug 5. pii: gutjnl-2019-318760. doi: 10.1136/gutjnl-2019-318760.
    PubMed     Abstract available


    July 2019
  22. LIAO P, Jia F, Teer JK, Knepper TC, et al
    Geographic variation in molecular subtype for gastric adenocarcinoma.
    Gut. 2019;68:1340-1341.
    PubMed    


    June 2019
  23. RUGGE M, Sacchi D, Graham DY, Genta RM, et al
    Secondary prevention of gastric cancer: merging the endoscopic atrophic border with OLGA staging.
    Gut. 2019 Jun 11. pii: gutjnl-2019-319107. doi: 10.1136/gutjnl-2019-319107.
    PubMed    


    May 2019
  24. XU C, Ooi WF, Qamra A, Tan J, et al
    HNF4alpha pathway mapping identifies wild-type IDH1 as a targetable metabolic node in gastric cancer.
    Gut. 2019 May 8. pii: gutjnl-2018-318025. doi: 10.1136/gutjnl-2018-318025.
    PubMed     Abstract available


    April 2019
  25. QUACH DT, Hiyama T, Gotoda T
    Do subjects with mild or moderate atrophic gastritis or intestinal metaplasia confined to the antrum benefit from gastric cancer surveillance?
    Gut. 2019 Apr 27. pii: gutjnl-2019-318720. doi: 10.1136/gutjnl-2019-318720.
    PubMed    


  26. DEN HOLLANDER WJ, Holster IL, den Hoed CM, Capelle LG, et al
    Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions.
    Gut. 2019;68:585-593.
    PubMed     Abstract available


    March 2019
  27. CAI Q, Zhu C, Yuan Y, Feng Q, et al
    Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study.
    Gut. 2019 Mar 29. pii: gutjnl-2018-317556. doi: 10.1136/gutjnl-2018-317556.
    PubMed     Abstract available


  28. WANG P, Wang Y, Langley SA, Zhou YX, et al
    Diverse tumour susceptibility in Collaborative Cross mice: identification of a new mouse model for human gastric tumourigenesis.
    Gut. 2019 Mar 6. pii: gutjnl-2018-316691. doi: 10.1136/gutjnl-2018-316691.
    PubMed     Abstract available


    January 2019
  29. LIN C, He H, Liu H, Li R, et al
    Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer.
    Gut. 2019 Jan 19. pii: gutjnl-2018-316324. doi: 10.1136/gutjnl-2018-316324.
    PubMed     Abstract available


  30. LI T, Guo H, Li H, Jiang Y, et al
    MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia.
    Gut. 2019 Jan 11. pii: gutjnl-2017-315318. doi: 10.1136/gutjnl-2017-315318.
    PubMed     Abstract available


  31. RAHN S, Kruger S, Rocken C, Helm O, et al
    Response to: 'Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma'.
    Gut. 2019;68:179-180.
    PubMed    


    September 2018
  32. WANG DS, Liu ZX, Lu YX, Bao H, et al
    Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer.
    Gut. 2018 Sep 29. pii: gutjnl-2018-316522. doi: 10.1136/gutjnl-2018-316522.
    PubMed     Abstract available


    July 2018
  33. CHUANG SC, Lin CC, Peng CY, Huang WH, et al
    Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study.
    Gut. 2018 Jul 17. pii: gutjnl-2018-316899. doi: 10.1136/gutjnl-2018-316899.
    PubMed    


  34. MOAYYEDI P, Veldhuyzen van Zanten SJO, Hookey L, Armstrong D, et al
    Proton pump inhibitors and gastric cancer: association is not causation.
    Gut. 2018 Jul 13. pii: gutjnl-2018-316958. doi: 10.1136/gutjnl-2018-316958.
    PubMed    


    May 2018
  35. KOBAYASHI J, Uchida H, Ito J
    Long-term proton pump inhibitor use after Helicobacter pylori eradication may create a gastric environment for N-nitrosamine formation and gastric cancer development.
    Gut. 2018 May 25. pii: gutjnl-2018-316592. doi: 10.1136/gutjnl-2018-316592.
    PubMed    


    April 2018
  36. SEIDLITZ T, Merker SR, Rothe A, Zakrzewski F, et al
    Human gastric cancer modelling using organoids.
    Gut. 2018 Apr 27. pii: gutjnl-2017-314549. doi: 10.1136/gutjnl-2017-314549.
    PubMed     Abstract available


  37. LAI SW, Lai HC, Lin CL, Liao KF, et al
    Proton pump inhibitors and risk of gastric cancer in a case-control study.
    Gut. 2018 Apr 16. pii: gutjnl-2018-316371. doi: 10.1136/gutjnl-2018-316371.
    PubMed    


  38. WAN QY, Wu XT, Li N, Du L, et al
    Long-term proton pump inhibitors use and risk of gastric cancer: a meta-analysis of 926 386 participants.
    Gut. 2018 Apr 3. pii: gutjnl-2018-316416. doi: 10.1136/gutjnl-2018-316416.
    PubMed    


    March 2018
  39. COOK MB, Coburn SB, Lam JR, Taylor PR, et al
    Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort.
    Gut. 2018;67:418-529.
    PubMed     Abstract available


    February 2018
  40. PENG YC, Huang LR, Lin CL, Hsu WY, et al
    Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD.
    Gut. 2018 Feb 22. pii: gutjnl-2018-316057. doi: 10.1136/gutjnl-2018-316057.
    PubMed    


  41. FERREIRA RM, Pereira-Marques J, Pinto-Ribeiro I, Costa JL, et al
    Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota.
    Gut. 2018;67:226-236.
    PubMed     Abstract available


    January 2018
  42. DOORAKKERS E, Lagergren J, Engstrand L, Brusselaers N, et al
    Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population.
    Gut. 2018 Jan 30. pii: gutjnl-2017-315363. doi: 10.1136/gutjnl-2017-315363.
    PubMed     Abstract available


  43. LATERZA L, Scaldaferri F, Gasbarrini A
    Risk factors for gastric cancer: is it time to discard PPIs?
    Gut. 2018 Jan 13. pii: gutjnl-2017-315621. doi: 10.1136/gutjnl-2017-315621.
    PubMed    


  44. RUGGE M, Meggio A, Pravadelli C, Barbareschi M, et al
    Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.
    Gut. 2018 Jan 6. pii: gutjnl-2017-314600. doi: 10.1136/gutjnl-2017-314600.
    PubMed     Abstract available


  45. SUISSA S, Suissa A
    Proton-pump inhibitors and increased gastric cancer risk: time-related biases.
    Gut. 2018 Jan 3. pii: gutjnl-2017-315729. doi: 10.1136/gutjnl-2017-315729.
    PubMed    


    December 2017
  46. NIIKURA R, Hayakawa Y, Hirata Y, Yamada A, et al
    Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis.
    Gut. 2017 Dec 22. pii: gutjnl-2017-315710. doi: 10.1136/gutjnl-2017-315710.
    PubMed    


  47. SUZUKI H, Matsuzaki J
    Helicobacter pylori eradication failure may have confounded the recent large-scale health database study that showed proton pump inhibitors increase gastric cancer risk.
    Gut. 2017 Dec 15. pii: gutjnl-2017-315698. doi: 10.1136/gutjnl-2017-315698.
    PubMed    


    November 2017
  48. GUETA I, Halkin H, Markovits N, Loebstein R, et al
    Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B 12.
    Gut. 2017 Nov 28. pii: gutjnl-2017-315695. doi: 10.1136/gutjnl-2017-315695.
    PubMed    


  49. WALDUM HL, Fossmark R
    Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man.
    Gut. 2017 Nov 20. pii: gutjnl-2017-315629. doi: 10.1136/gutjnl-2017-315629.
    PubMed    



  50. Erratum: Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids.
    Gut. 2017;66:2012.
    PubMed    


    October 2017
  51. CHEUNG KS, Chan EW, Wong AYS, Chen L, et al
    Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study.
    Gut. 2017 Oct 31. pii: gutjnl-2017-314605. doi: 10.1136/gutjnl-2017-314605.
    PubMed     Abstract available


    September 2017
  52. CHEN IF, Liu KW, Tang TQ, Wang WL, et al
    An unusual gastric tumour with gastric outlet obstruction.
    Gut. 2017 Sep 28. pii: gutjnl-2017-315087. doi: 10.1136/gutjnl-2017-315087.
    PubMed    


  53. YAN C, Zhu M, Huang T, Yu F, et al
    Genome-wide association studies identified loci contribute to phenotypic variance of gastric cancer.
    Gut. 2017 Sep 22. pii: gutjnl-2017-315230. doi: 10.1136/gutjnl-2017-315230.
    PubMed    


  54. NOTO JM, Chopra A, Loh JT, Romero-Gallo J, et al
    Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments.
    Gut. 2017 Sep 18. pii: gutjnl-2017-313863. doi: 10.1136/gutjnl-2017-313863.
    PubMed     Abstract available


    August 2017
  55. RAJENDRAN S, Benna C, Monticelli H, Spiro G, et al
    Germline variation of circadian pathway genes and prognosis of gastric cancer patients.
    Gut. 2017 Aug 8. pii: gutjnl-2017-314740. doi: 10.1136/gutjnl-2017-314740.
    PubMed    


  56. COKER OO, Dai Z, Nie Y, Zhao G, et al
    Mucosal microbiome dysbiosis in gastric carcinogenesis.
    Gut. 2017 Aug 1. pii: gutjnl-2017-314281. doi: 10.1136/gutjnl-2017-314281.
    PubMed     Abstract available


    June 2017
  57. HUANG LY, Wang X, Cui XF, Li H, et al
    IRTKS is correlated with progression and survival time of patients with gastric cancer.
    Gut. 2017 Jun 24. pii: gutjnl-2016-313478. doi: 10.1136/gutjnl-2016-313478.
    PubMed     Abstract available


  58. MERA RM, Bravo LE, Camargo MC, Bravo JC, et al
    Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial.
    Gut. 2017 Jun 24. pii: gutjnl-2016-311685. doi: 10.1136/gutjnl-2016-311685.
    PubMed     Abstract available


    May 2017
  59. SIERRA JC, Asim M, Verriere TG, Piazuelo MB, et al
    Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.
    Gut. 2017 May 4. pii: gutjnl-2016-312888. doi: 10.1136/gutjnl-2016-312888.
    PubMed     Abstract available


  60. THOMPSON ED, Zahurak M, Murphy A, Cornish T, et al
    Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma.
    Gut. 2017;66:794-801.
    PubMed     Abstract available


    April 2017
  61. WANG Z, Dai J, Hu N, Miao X, et al
    Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies.
    Gut. 2017;66:581-587.
    PubMed     Abstract available


    March 2017
  62. ZHANG X, Xu W
    Neutrophils diminish T-cell immunity to foster gastric cancer progression: the role of GM-CSF/PD-L1/PD-1 signalling pathway.
    Gut. 2017 Mar 27. pii: gutjnl-2017-313923. doi: 10.1136/gutjnl-2017-313923.
    PubMed    


  63. WANG TT, Zhao YL, Peng LS, Chen N, et al
    Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway.
    Gut. 2017 Mar 8. pii: gutjnl-2016-313075. doi: 10.1136/gutjnl-2016-313075.
    PubMed     Abstract available


    December 2016
  64. MAEDA M, Nakajima T, Oda I, Shimazu T, et al
    High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study.
    Gut. 2016 Dec 21. pii: gutjnl-2016-313387. doi: 10.1136/gutjnl-2016-313387.
    PubMed    


    October 2016
  65. MALFERTHEINER P, Megraud F, O'Morain CA, Gisbert JP, et al
    Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
    Gut. 2016 Oct 5. pii: gutjnl-2016-312288. doi: 10.1136/gutjnl-2016-312288.
    PubMed     Abstract available


    September 2016
  66. ZHU S, Soutto M, Chen Z, Peng D, et al
    Helicobacter pylori-induced cell death is counteracted by NF-kappaB-mediated transcription of DARPP-32.
    Gut. 2016 Sep 2. pii: gutjnl-2016-312141. doi: 10.1136/gutjnl-2016-312141.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: